Truist Securities Maintains Buy on Astrana Health, Raises Price Target to $47

Benzinga Newsdesk www.benzinga.com Positive 72.5%

Neg 0% Neu 0% Pos 72.5%

Truist Securities analyst Jailendra Singh maintains Astrana Health (NASDAQ:ASTH) with a Buy and raises the price target from $38 to $47.